Aquinox to Participate in Two Upcoming Investor Events
December 10, 2015 09:15 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Dec. 10, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Reports Third Quarter 2015 Financial Results
November 10, 2015 09:15 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Results From Phase 2 KINSHIP Trial With AQX-1125 in Patients With Atopic Dermatitis
November 02, 2015 20:15 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 02, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing...
Aquinox to Host R&D Day in New York
September 21, 2015 09:15 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Presents at 2015 International Society for the Study of BPS Conference
September 18, 2015 09:15 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 18, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Announces Closing of $98.0 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
September 16, 2015 09:15 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 16, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Prices Public Offering of Common Stock
September 09, 2015 22:10 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 9, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Proposed Public Offering of Common Stock
September 08, 2015 16:01 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
LEADERSHIP Results Accepted for Podium Presentation at the 2015 Annual Meeting of the International Society for the Study of BPS (ESSIC)
August 25, 2015 09:15 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Aug. 25, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Positive Results From Secondary Endpoints From Phase 2 LEADERSHIP Trial in BPS/IC and Reports Second Quarter 2015 Financial Results
August 06, 2015 16:15 ET
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...